Learn More
Medchemexpress LLC TBI-223 | 2071265-08-0 | 99.7% | 365.36 | 50 MG

Supplier: Medchemexpress LLC HY13939850MG
TBI-223 is an orally active oxazolidinone antibiotic and an antimicrobial that demonstrates activity against Mycobacterium tuberculosis (Mtb). It exhibits an IC50 of 68 μg/mL for inhibiting mitochondrial protein synthesis (MPS) in HepG2 cells. It has shown effectiveness in three mouse models of methicillin-resistant Staphylococcus aureus infection, and can be utilized for the study of tuberculosis.
- Orally active oxazolidinone antibiotic
- Antimicrobial activity against Mycobacterium tuberculosis (Mtb)
- Inhibits mitochondrial protein synthesis (MPS) in HepG2 cells
- Effective in mouse models of methicillin-resistant Staphylococcus aureus infection
- Used for the study of tuberculosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.